Cite

HARVARD Citation

    Nantes, Ó. et al. (2014). Letter: the feasibility and safety of accelerated infliximab infusions in patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics. 39 (4), pp. 444-445. [Online]. 
  
Back to record